71 related articles for article (PubMed ID: 10096283)
21. Cell-specific and efficient expression in mouse and human B cells by a novel hybrid immunoglobulin promoter in a lentiviral vector.
Laurie KL; Blundell MP; Baxendale HE; Howe SJ; Sinclair J; Qasim W; Brunsberg U; Thrasher AJ; Holmdahl R; Gustafsson K
Gene Ther; 2007 Dec; 14(23):1623-31. PubMed ID: 17851547
[TBL] [Abstract][Full Text] [Related]
22. Tetracycline-mediated regulation of gene expression within the human cytomegalovirus genome.
McVoy MA; Mocarski ES
Virology; 1999 Jun; 258(2):295-303. PubMed ID: 10366566
[TBL] [Abstract][Full Text] [Related]
23. Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1alpha promoter.
Gill DR; Smyth SE; Goddard CA; Pringle IA; Higgins CF; Colledge WH; Hyde SC
Gene Ther; 2001 Oct; 8(20):1539-46. PubMed ID: 11704814
[TBL] [Abstract][Full Text] [Related]
24. A gene regulation system with four distinct expression levels.
Krueger C; Danke C; Pfleiderer K; Schuh W; Jäck HM; Lochner S; Gmeiner P; Hillen W; Berens C
J Gene Med; 2006 Aug; 8(8):1037-47. PubMed ID: 16779863
[TBL] [Abstract][Full Text] [Related]
25. Promoters influence the kinetics of transgene expression following adenovector gene delivery.
Chen P; Tian J; Kovesdi I; Bruder JT
J Gene Med; 2008 Feb; 10(2):123-31. PubMed ID: 18064718
[TBL] [Abstract][Full Text] [Related]
26. Lentiviral vectors efficiently transduce human gonadotroph and somatotroph adenomas in vitro. Targeted expression of transgene by pituitary hormone promoters.
Roche C; Zamora AJ; Taïeb D; Lavaque E; Rasolonjanahary R; Dufour H; Bagnis C; Enjalbert A; Barlier A
J Endocrinol; 2004 Oct; 183(1):217-33. PubMed ID: 15525589
[TBL] [Abstract][Full Text] [Related]
27. Improved neuronal transgene expression from an AAV-2 vector with a hybrid CMV enhancer/PDGF-beta promoter.
Wang CY; Guo HY; Lim TM; Ng YK; Neo HP; Hwang PY; Yee WC; Wang S
J Gene Med; 2005 Jul; 7(7):945-55. PubMed ID: 15756650
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of a synthetic CArG promoter for nitric oxide synthase gene therapy of cancer.
Worthington J; Robson T; Scott S; Hirst D
Gene Ther; 2005 Oct; 12(19):1417-23. PubMed ID: 15902277
[TBL] [Abstract][Full Text] [Related]
29. Gene transfer system derived from the caprine arthritis-encephalitis lentivirus.
Mselli-Lakhal L; Guiguen F; Greenland T; Mornex JF; Chebloune Y
J Virol Methods; 2006 Sep; 136(1-2):177-84. PubMed ID: 16797087
[TBL] [Abstract][Full Text] [Related]
30. A comparison of enhanced green fluorescent protein expression induced by immediate-early cytomegalovirus (IE-CMV) and gG pseudorabies virus (gG-PRV) promoters, using pseudorabies virus amplicons as vectors.
Muñoz AL; Prieto C; Tabarés E
J Virol Methods; 2006 Sep; 136(1-2):257-60. PubMed ID: 16712964
[TBL] [Abstract][Full Text] [Related]
31. Gene transduction efficiency in cells of different species by HIV and EIAV vectors.
Ikeda Y; Collins MK; Radcliffe PA; Mitrophanous KA; Takeuchi Y
Gene Ther; 2002 Jul; 9(14):932-8. PubMed ID: 12085241
[TBL] [Abstract][Full Text] [Related]
32. Liver-specific expression of interferon gamma following adenoviral gene transfer controls hepatitis B virus replication in mice.
Dumortier J; Schönig K; Oberwinkler H; Löw R; Giese T; Bujard H; Schirmacher P; Protzer U
Gene Ther; 2005 Apr; 12(8):668-77. PubMed ID: 15647761
[TBL] [Abstract][Full Text] [Related]
33. Activator protein 1-mediated transcriptional regulation strategy sustains long-term expression of a xenogeneic gene product in vivo: an implication for gene therapy targeting congenital protein deficiencies.
Sasaki S; Smith JM; Takase K; Okuda K; Ishii N; Takeshita F
Int J Mol Med; 2006 Aug; 18(2):289-97. PubMed ID: 16820937
[TBL] [Abstract][Full Text] [Related]
34. Improved lentiviral vectors for Wiskott-Aldrich syndrome gene therapy mimic endogenous expression profiles throughout haematopoiesis.
Frecha C; Toscano MG; Costa C; Saez-Lara MJ; Cosset FL; Verhoeyen E; Martin F
Gene Ther; 2008 Jun; 15(12):930-41. PubMed ID: 18323794
[TBL] [Abstract][Full Text] [Related]
35. Optimization of tetracycline-responsive recombinant protein production and effect on cell growth and ER stress in mammalian cells.
Jones J; Nivitchanyong T; Giblin C; Ciccarone V; Judd D; Gorfien S; Krag SS; Betenbaugh MJ
Biotechnol Bioeng; 2005 Sep; 91(6):722-32. PubMed ID: 15981277
[TBL] [Abstract][Full Text] [Related]
36. Sustained expression after nonviral ocular gene transfer using mammalian promoters.
Kachi S; Esumi N; Zack DJ; Campochiaro PA
Gene Ther; 2006 May; 13(9):798-804. PubMed ID: 16467860
[TBL] [Abstract][Full Text] [Related]
37. Lentiviral vectors: regulated gene expression.
Kafri T; van Praag H; Gage FH; Verma IM
Mol Ther; 2000 Jun; 1(6):516-21. PubMed ID: 10933976
[TBL] [Abstract][Full Text] [Related]
38. [Expression of adenovirus-mediated pGH cDNA with first intron in CHO cells].
Li XJ; Zhong F; Wang XZ; Qi SZ
Sheng Wu Gong Cheng Xue Bao; 2002 Jan; 18(2):193-7. PubMed ID: 12148282
[TBL] [Abstract][Full Text] [Related]
39. Promoters and serotypes: targeting of adeno-associated virus vectors for gene transfer in the rat central nervous system in vitro and in vivo.
Shevtsova Z; Malik JM; Michel U; Bähr M; Kügler S
Exp Physiol; 2005 Jan; 90(1):53-9. PubMed ID: 15542619
[TBL] [Abstract][Full Text] [Related]
40. Muscle stem cells can act as antigen-presenting cells: implication for gene therapy.
Cao B; Bruder J; Kovesdi I; Huard J
Gene Ther; 2004 Sep; 11(17):1321-30. PubMed ID: 15175641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
